Media News

Bridge Biotherapeutics Presents Pre-Clinical Data of BBT-176 at the European Society for Medical Oncology (ESMO) Virtual Congress 2021

Pre-clinical data exploring the in vitro and in vivo efficacy of BBT-176 will be disclosed via an ePoster at the ESMO Congress 2021 Patient dosing for the phase 1/2 clinical study of BBT-176 was initiated in April 2021…the topline data of the first-in-human, dose escalation study is expected to be announced in 2022 SEONGNAM,...

PharmaZell and Novasep enter into exclusive negotiations in new drive to create a technology-driven leader for complex small molecules and ADCs of global scale

RAUBLING, Germany and LYON, France, Sept. 17, 2021 /PRNewswire/ -- PharmaZell, the German producer of highly resilient and specialty APIs, and France-based Novasep, a leading CDMO focused on complex small molecules and ADCs have entered into exclusive negotiations to create a leading European platform in the attractive API manufacturing and CDMO space with...

Satisfai Health acquires global license for AI software to detect early cancer in Barrett’s Esophagus

Advanced real-time clinical diagnostics for up to 150 million people VANCOUVER, BC, Sept. 16, 2021 /PRNewswire/ -- Satisfai Health, a leading medical solutions provider specializing in artificial intelligence (AI) applications, particularly in Gastrointestinal Endoscopy, has acquired an exclusive global license from the University of Augsburg and the OTH Regensburg, Technical University of Applied...

Syapse Awarded 2021 Technology Innovation Leadership Award by Frost & Sullivan for Accelerating Real-world Care Delivery

Syapse's three-pronged approach offers a complete service cycle, helping health systems, providers, and life science organizations to improve cancer care quality SANTA CLARA, Calif., Sept. 16, 2021 /PRNewswire/ -- Based on its recent analysis of the global oncology data-sharing software platform market, Frost & Sullivan recognizes Syapse, Inc (Syapse) with the 2021 Global Technology Innovation Leadership Award in the...

Validic Empowers Physicians and Care Managers to Manage Personal Health Data at Scale

Validic's best-in-class strategy is supported by its deep integration into clinical workflows and care pathways and its simple application design for consumer engagement SANTA CLARA, Calif., Sept. 16, 2021 /PRNewswire/ -- Based on its recent analysis of the North American remote patient monitoring (RPM) market, Frost & Sullivan recognizes Validic, Inc. with the...

Tom Golisano Gifts $30 Million to Special Olympics to Expand Critical Health Services Globally for People with Intellectual Disabilities

WASHINGTON, Sept. 16, 2021 /PRNewswire/ -- Special Olympics announced today that it has received its largest single private gift in the organization's 53-year history. Tom Golisano, Paychex founder, philanthropist and father of a son with an intellectual disability, will provide $30 million, his third major gift to Special Olympics, to expand the Special Olympics Healthy Communities program, which provides health services...

COVID-19 Scoop: Epoch-Making GoldenBiotech’s Oral COVID-19 New Drug Trial Got Green Light from the FDA to Extend Recruiting Severe COVID-19 Patients

TAIPEI, Sept.16, 2021 /PRNewswire/ -- Golden Biotechnology Corp.(TPEx:4132) ("GoldenBiotech", GBC), a leading Taiwanese biopharmaceutical company, announces that its oral investigational new drug Antroquinonol (HOCENA®) has made headway with COVID-19 treatment development in more broaden clinical trial patients permitted in inclusion severity as well as future marketing expansion by signing a new international MOU for cooperation and development of...

Laekna Therapeutics reported positive results in two clinical studies for the treatment of various stages of prostate cancer at the ESMO Congress

SHANGHAI and WARREN, New Jersey, Sept. 16, 2021 /PRNewswire/ -- Laekna Therapeutics, an emerging innovative biotech company based in China's "Zhangjiang Pharma Valley" and New Jersey, USA, focusing on the development of ground-breaking innovative therapies to treat cancer and liver diseases, reported positive results in two clinical studies for the treatment of early and late stages of prostate cancer...

Key milestone: DHL delivers 1 billion COVID-19 vaccine doses

1 billion vaccine doses shipped to more than 160 countries in the fight against COVID-19 since December 2020 Smooth management and execution of different supply chain set-ups Planning essential to identify and prevent future health emergencies SINGAPORE, Sept. 16, 2021 /PRNewswire/ -- COVID-19 has become the largest global...

PR Newswire’s 2021 Healthcare Media Pitching Kit (APAC Edition) Reveals News and Trends Journalists Seek from Brands

HONG KONG, Sept. 16, 2021 /PRNewswire/-- COVID-19 related stories will stay dominant in healthcare media coverage and journalists are keen to report on medical innovations, scientific discoveries and technical applications, according to PR Newswire's 2021 Healthcare Media Pitching Kit (APAC Edition), which aims to advise brands on pitching to healthcare media effectively. ...